Meir Peleg - 14 Aug 2026 Form 4 Insider Report for IceCure Medical Ltd. (ICCM)

Reporting relationship: Chief Financial Officer
Issuer ticker: ICCM
Reported as of: 14 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Aug 2026, 08:15:38 UTC
Prior SEC filing: 18 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Meir Peleg

Key filing fact

Meir Peleg filed Form 4 for IceCure Medical Ltd. (ICCM) on 17 Aug 2026.

Key facts

This page summarizes Meir Peleg's Form 4 filing for IceCure Medical Ltd. (ICCM).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Aug 2026, 08:15.

Change

Previous filing in this sequence was filed on 18 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002131274 Primary reporting owner

Peleg Meir

Relationship: Chief Financial Officer
Address: 7 HA'ESHEL ST., PO BOX 3163, CAESAREA, ISRAEL
Signature: /s/ Meir Peleg
Signature date: 17 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ICCM transaction

Ordinary Shares

Award

Transaction value
Shares: +181,483
Change %: +1361%
Price: $0.000000^*
Shares after: 194,816
Date: 14 Aug 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents (i) 181,483 restricted share units ("RSUs") granted on August 14, 2026, 25% of which vest on August 11, 2027, and the remaining 75% vest in twelve equal quarterly installments of 6.25% thereafter, and (ii) 13,333 RSUs granted on May 17, 2026, 25% of which vest on May 17, 2027, and the remaining 75% vest in twelve equal quarterly installments of 6.25% thereafter. All of the foregoing RSUs remain unvested as of August 13, 2026. The holdings described in clause (ii) has been adjusted to reflect the Issuer's 1-for-30 reverse share split effected on June 4, 2026.